Neuland Laboratories Limited (NSE:NEULANDLAB)
India · Delayed Price · Currency is INR 13,865
+137 (1.00%)
Sep 3, 2025, 9:43 AM IST
Neuland Laboratories Market Cap
Neuland Laboratories has a market cap or net worth of 175.91 billion as of September 2, 2025. Its market cap has increased by 18.63% in one year.
Market Cap
175.91B
Enterprise Value
175.09B
Revenue
13.30B
Ranking
n/a
PE Ratio
99.87
Stock Price
13,865.00
Market Cap Chart
Since December 18, 2000, Neuland Laboratories's market cap has increased from 335.14M to 175.91B, an increase of 52,389.91%. That is a compound annual growth rate of 28.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2025 | 175.91B | -0.12% |
| Dec 31, 2024 | 176.13B | 159.63% |
| Dec 29, 2023 | 67.84B | 216.90% |
| Dec 30, 2022 | 21.41B | 7.77% |
| Dec 31, 2021 | 19.86B | 41.44% |
| Dec 31, 2020 | 14.04B | 161.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,825.74B |
| Divi's Laboratories | 1,627.72B |
| Cipla | 1,283.84B |
| Apollo Hospitals Enterprise | 1,094.20B |
| Mankind Pharma | 1,020.09B |
| Zydus Lifesciences | 987.17B |
| Fortis Healthcare | 688.14B |
| Alkem Laboratories | 634.11B |